Newsletters

Newsletters

CALIBRE Easter 2019 Newsletter

CALIBRE Christmas 2018 Newsletter

CALIBRE Autumn 2018 Newsletter

 Publications

CALIBRE Study Protocol : https://bmjopengastro.bmj.com/content/6/1/e000290

Related Research:

Trivedi PJ, Bruns T, Cheung A, Li KK, Kittler C, Kumagi T, et al. Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response. J Hepatol. 2014;60(6):1249-58.

Buchholz BM, Khan S, David MD, Gunson BK, Isaac JR, Roberts KJ, et al. Retransplantation in Late Hepatic Artery Thrombosis: Graft Access and Transplant Outcome. Transplant Direct. 2017;3(8):e186.

Rowe IA, Tripathi D. Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma. Aliment Pharmacol Ther. 2015;41(2):230. 

Leithead JA, Rajoriya N, Tehami N, Hodson J, Gunson BK, Tripathi D, et al. Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut. 2015;64(7):1111-9.

Tripathi D, Sunderraj L, Vemala V, Mehrzad H, Zia Z, Mangat K, et al. Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome. Liver Int. 2017;37(1):111-20.

Tripathi D, Macnicholas R, Kothari C, Sunderraj L, Al-Hilou H, Rangarajan B, et al. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther. 2014;39(8):864-72. 

Harding DJ, Perera MT, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol. 2015;21(22):6769-84.

Rajoriya N, Tripathi D, Leithead JA, Gunson BK, Lord S, Ferguson JW, et al. Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes. World J Gastroenterol. 2016;22(45):9966-73.